SuO039LONG TERM EFFECTS OF OCTREOTIDE TREATMENT IN ADPKD PATIENTS WITH POLYCYSTIC LIVER DISEASE (A SUB-GROUP ANALYSIS OF THE ALADIN TRIAL)

Antonio Pisani; Piero Ruggenenti; Giuseppe Remuzzi; Eleonora Riccio; Massimo Sabbatini

doi:10.1093/ndt/gfv163.01

Related publications

Article2016

Long-term Effects of Octreotide on Liver Volume in Patients With Polycystic Kidney and Liver Disease

Antonio Pisani, Massimo Sabbatini, Massimo Imbriaco, Eleonora Riccio, Nadia Rubis, Anna Prinster, Annalisa Perna, Raffaele Liuzzi, Letìzia Spinelli, Michele Santangelo, Giuseppe Remuzzi, Piero Ruggenenti, Antonio Pisani, Massimo Sabbatini, Piero Ruggenenti, Giuseppe Remuzzi, Antonio Pisani, Bianca Visciano, Maria Amicone, Renata Angela DiPietro, Giusi Rosaria Mozzillo, Eleonora Riccio, R. Rossano, Massimo Sabbatini, Letìzia Spinelli, Michele Santangelo, Nadia Rubis, Olimpia Diadei, Wally Calini, Alessandro Villa, Mary Ellen Sabatella, Bogdan Ene‐Iordache, Sergio Carminati, Davide Martinetti, Giovanni Giuliano, Annalisa Perna, Raffaele Liuzzi, Andrea Remuzzi, Massimo Imbriaco, Anna Prinster, M. Altiero, Paola Boccardo, S. Peracchi

Article2018

Left ventricular dysfunction in ADPKD and effects of octreotide-LAR: A cross-sectional and longitudinal substudy of the ALADIN trial

Letìzia Spinelli, Antonio Pisani, Giuseppe Giugliano, Bruno Trimarco, Eleonora Riccio, Bianca Visciano, Giuseppe Remuzzi, Piero Ruggenenti

Article2019

Octreotide-LAR in later-stage autosomal dominant polycystic kidney disease (ALADIN 2): A randomized, double-blind, placebo-controlled, multicenter trial

Norberto Perico, Piero Ruggenenti, Annalisa Perna, Anna Caroli, Matias Trillini, Sandro Sironi, Antonio Pisani, Eleonora Riccio, Massimo Imbriaco, Mauro Dugo, Giovanni Morana, Antonio Granata, Michele Figuera, Flavio Gaspari, Fabiola Carrara, Nadia Rubis, Alessandro Villa, Sara Gamba, Silvia Prandini, Monica Cortinovis, Andrea Remuzzi, Giuseppe Remuzzi

Article2023

Effects of Octreotide–Long-Acting Release Added-on Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease: Pilot, Randomized, Placebo-Controlled, Cross-Over Trial

Matias Trillini, Anna Caroli, Norberto Perico, Andrea Remuzzi, Paolo Brambilla, Giulia Villa, Annalisa Perna, Tobia Peracchi, Nadia Rubis, Davide Martinetti, Rosa Caruso, Valentina Fanny Leone, Daniela Cugini, Fabiola Carrara, Giuseppe Remuzzi, Piero Ruggenenti

Article2022

Octreotide Lar in Patients with Autosomal Dominant Polycystic Kidney Disease: From Bench to A Novel Perspective of Therapy

Piero Ruggenenti, Annalisa Perna, Anna Caroli, Norberto Perico, Mattias Trillini, Antonio Pisani, Letìzia Spinelli, Giuseppe Remuzzi